Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 1998, p. 1028-1031, Vol. 36, No. 4
Public Health Laboratory, Orange County
Health Care Agency, Santa Ana, California 92706
Received 31 October 1997/Returned for modification 19 December
1997/Accepted 15 January 1998
Sputum specimens received for the diagnosis of tuberculosis or
other mycobacterial infections were tested by a ligase chain reaction
(LCR)-based assay and acid-fast stain and culture techniques. Results
from the LCR assay (Abbott LCx Mycobacterium tuberculosis [MTB] Assay) were compared to results from standard culture
techniques held for 6 weeks. Four hundred ninety-three specimens from
205 patients suspected of pulmonary tuberculosis were included in the
prospective study. Thirty-four (6.9%) of the specimens were culture
positive for M. tuberculosis, and 13 (38%) of these were also fluorochrome stain positive. LCR sensitivities and specificities compared to culture were 74 and 98%, respectively. LCR sensitivity was
100% for fluorochrome stain-positive specimens and 57% for fluorochrome stain-negative specimens. Nine LCR-negative,
culture-positive specimens were the result of low concentrations of
M. tuberculosis. No inhibitors were detected in any of
these specimens. Of the eight LCR-positive, culture-negative specimens,
five were from patients with active tuberculosis. With these considered
culture misses, final LCR sensitivity, specificity, positive predictive value, and negative predictive value were 77, 99, 91, and 98%, respectively. The same performance values for the fluorochrome acid-fast bacillus smear were 33, 98, 62, and 94%, respectively. After
normal laboratory sputum processing, the Abbott LCx MTB Assay can be
completed in 6 h. Thus, it is possible to have results available
within 8 h of specimen submission.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection and Identification of Mycobacterium
tuberculosis Directly from Sputum Sediments by Ligase Chain
Reaction
*
Corresponding author. Mailing address: Orange County
Public Health Laboratory, 1729 W 17th St., Santa Ana, CA 92706. Phone: (714) 834-8385. Fax: (714) 834-7968. E-mail:
dmoore{at}hca.co.orange.ca.us.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|